Refine by
Locations
- Europe
- Albania
- Andorra
- Austria
- Belarus
- Belgium
- Bosnia & Herzegovina
- Bulgaria
- Croatia
- Cyprus
- Czech Republic
- Denmark
- Estonia
- Faroe Islands
- Finland
- France
- Germany
- Greece
- Hungary
- Iceland
- Ireland
- Italy
- Kosovo
- Latvia
- Liechtenstein
- Lithuania
- Luxembourg
- Macedonia
- Malta
- Moldova
- Monaco
- Montenegro
- Netherlands
- Northern Ireland
- Norway
- Poland
- Portugal
- Romania
- San Marino
- Serbia
- Slovakia
- Slovenia
- Spain
- Sweden
- Switzerland
- Turkey
- Ukraine
- United Kingdom
- Vatican City
Stent Material Equipment Supplied In Europe
7 equipment items found
Manufactured by:MeKo Manufacturing e.K. based inSarstedt / Hannover, GERMANY
Function: Corronary stents. Material: CoCr L605. Stainless Steel 316 ...
Manufactured by:MicroPort Scientific Corporation based inShanghai, CHINA
Extraordinary Deliverability. Ultra Low Profile. Target Eluting Technology of ...
Manufactured by:MicroPort Scientific Corporation based inShanghai, CHINA
TARGET All Comers Trial: 1,656 Patients from 20 sites in Europe. 1:1 RCT Real World open-label, non-inferiority trial Primary endpoint: TLF @12 months. Confirms that the Firehawk®, a low dose sirolimus eluting biodegradable polymer DES, is safe. and effective across a broad spectrum of patient and lesion complexity. ...
Manufactured by:MeKo Manufacturing e.K. based inSarstedt / Hannover, GERMANY
Function: Stent for peripheral implantation. Material: Nitinol (NiTi) ø 3 ...
Manufactured by:Terumo Aortic based inRenfrewshire, UNITED KINGDOM
RELAY®Pro is designed for maximum precision and control in the thoracic ...
Manufactured by:Becton Dickinson and Company (BD) based inFranklin Lakes, NEW JERSEY (USA)
Tepha is developing fully absorbable stents and coatings made from TephaFLEX® material. This could allow for local drug elution while leaving no permanent residual polymer, which might address the issue of late stent thrombosis with current DESs. In addition, Tepha is developing fully absorbable polymer stents containing ...
Manufactured by:Veryan Medical Ltd. based inHorsham, UNITED KINGDOM
The Challenge: Peripheral Arterial Disease. People are living longer and with an increase in the incidence of obesity, diabetes and other contributing factors, claudication may cause substantial tissue changes and, in some scenarios, can lead to amputation and even death. The peripheral stent market is forecast to grow to $2 billion by 2024 driven by technological advances, an ageing population ...